684 related articles for article (PubMed ID: 30540938)
1. Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells.
Benjamin D; Robay D; Hindupur SK; Pohlmann J; Colombi M; El-Shemerly MY; Maira SM; Moroni C; Lane HA; Hall MN
Cell Rep; 2018 Dec; 25(11):3047-3058.e4. PubMed ID: 30540938
[TBL] [Abstract][Full Text] [Related]
2. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
[TBL] [Abstract][Full Text] [Related]
3. Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis.
Van der Vreken A; Oudaert I; Ates G; Faict S; Vlummens P; Satilmis H; Fan R; Maes A; Massie A; De Veirman K; De Bruyne E; Vanderkerken K; Menu E
J Pathol; 2023 Jun; 260(2):112-123. PubMed ID: 36807305
[TBL] [Abstract][Full Text] [Related]
4. CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells.
Walters DK; Arendt BK; Jelinek DF
Cell Cycle; 2013 Oct; 12(19):3175-83. PubMed ID: 24013424
[TBL] [Abstract][Full Text] [Related]
5. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.
Curry JM; Tuluc M; Whitaker-Menezes D; Ames JA; Anantharaman A; Butera A; Leiby B; Cognetti DM; Sotgia F; Lisanti MP; Martinez-Outschoorn UE
Cell Cycle; 2013 May; 12(9):1371-84. PubMed ID: 23574725
[TBL] [Abstract][Full Text] [Related]
6. MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy.
Beloueche-Babari M; Wantuch S; Casals Galobart T; Koniordou M; Parkes HG; Arunan V; Chung YL; Eykyn TR; Smith PD; Leach MO
Cancer Res; 2017 Nov; 77(21):5913-5924. PubMed ID: 28923861
[TBL] [Abstract][Full Text] [Related]
7. Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.
Polański R; Hodgkinson CL; Fusi A; Nonaka D; Priest L; Kelly P; Trapani F; Bishop PW; White A; Critchlow SE; Smith PD; Blackhall F; Dive C; Morrow CJ
Clin Cancer Res; 2014 Feb; 20(4):926-937. PubMed ID: 24277449
[TBL] [Abstract][Full Text] [Related]
8. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.
Mikkilineni L; Whitaker-Menezes D; Domingo-Vidal M; Sprandio J; Avena P; Cotzia P; Dulau-Florea A; Gong J; Uppal G; Zhan T; Leiby B; Lin Z; Pro B; Sotgia F; Lisanti MP; Martinez-Outschoorn U
Semin Oncol; 2017 Jun; 44(3):218-225. PubMed ID: 29248133
[TBL] [Abstract][Full Text] [Related]
10.
Chou CH; Chiang CF; Yang CC; Liu YC; Chang SR; Chang KW; Lin SC
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769160
[TBL] [Abstract][Full Text] [Related]
11. MCT1 and MCT4 expression during myocardial ischemic-reperfusion injury in the isolated rat heart.
Zhu Y; Wu J; Yuan SY
Cell Physiol Biochem; 2013; 32(3):663-74. PubMed ID: 24030048
[TBL] [Abstract][Full Text] [Related]
12. A Holistic Evolutionary and 3D Pharmacophore Modelling Study Provides Insights into the Metabolism, Function, and Substrate Selectivity of the Human Monocarboxylate Transporter 4 (hMCT4).
Papakonstantinou E; Vlachakis D; Thireou T; Vlachoyiannopoulos PG; Eliopoulos E
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805725
[TBL] [Abstract][Full Text] [Related]
13. Monocarboxylate transporters 1 and 4: expression and regulation by PPARα in ovine ruminal epithelial cells.
Benesch F; Dengler F; Masur F; Pfannkuche H; Gäbel G
Am J Physiol Regul Integr Comp Physiol; 2014 Dec; 307(12):R1428-37. PubMed ID: 25320343
[TBL] [Abstract][Full Text] [Related]
14. Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice.
Aveseh M; Nikooie R; Aminaie M
J Physiol; 2015 Jun; 593(12):2635-48. PubMed ID: 25907793
[TBL] [Abstract][Full Text] [Related]
15. Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas.
Bonglack EN; Messinger JE; Cable JM; Ch'ng J; Parnell KM; Reinoso-Vizcaíno NM; Barry AP; Russell VS; Dave SS; Christofk HR; Luftig MA
Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34161263
[TBL] [Abstract][Full Text] [Related]
16. Testosterone increases lactate transport, monocarboxylate transporter (MCT) 1 and MCT4 in rat skeletal muscle.
Enoki T; Yoshida Y; Lally J; Hatta H; Bonen A
J Physiol; 2006 Nov; 577(Pt 1):433-43. PubMed ID: 16959859
[TBL] [Abstract][Full Text] [Related]
17. Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights.
Puri S; Juvale K
Eur J Med Chem; 2020 Aug; 199():112393. PubMed ID: 32388280
[TBL] [Abstract][Full Text] [Related]
18. Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis.
Doherty JR; Yang C; Scott KE; Cameron MD; Fallahi M; Li W; Hall MA; Amelio AL; Mishra JK; Li F; Tortosa M; Genau HM; Rounbehler RJ; Lu Y; Dang CV; Kumar KG; Butler AA; Bannister TD; Hooper AT; Unsal-Kacmaz K; Roush WR; Cleveland JL
Cancer Res; 2014 Feb; 74(3):908-20. PubMed ID: 24285728
[TBL] [Abstract][Full Text] [Related]
19. The expression of lactate transporters (MCT1 and MCT4) in heart and muscle.
Bonen A
Eur J Appl Physiol; 2001 Nov; 86(1):6-11. PubMed ID: 11820324
[TBL] [Abstract][Full Text] [Related]
20. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.
Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A
BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
